Use of repurposed and adjuvant drugs in hospital patients with COVID-19: multinational network cohort study
<p><strong>Objective:</strong><br /> To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents.</p><br /> <p><strong>Design:</strong><br /> Multinational network cohort s...
Main Authors: | Prats Uribe, A, Sena, AG, Lai, LYH, Ahmed, W, Morgado Areia, C, Shah, K, Lane, J, Burn, E, Prieto Alhambra, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Similar Items
-
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
by: Burn, E, et al.
Published: (2020) -
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
by: Lane, JCE, et al.
Published: (2020) -
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
by: Lane, JCE, et al.
Published: (2020) -
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
by: Tan, EH, et al.
Published: (2021) -
Partial knee replacement is associated with a lower risk of venous thromboembolism and opioid use than total knee replacement but increased risk of long-term revision: a multinational, multi-database, propensity score-matched, cohort analysis including over 280,000 patients
by: Prieto-Alhambra, D, et al.
Published: (2019)